The Elephant in The Room: AML Relapse Post Allogeneic Hematopoietic Cell Transplantation

被引：8
作者：
Abou Dalle, Iman [1 ]
Atoui, Ali [1 ]
Bazarbachi, Ali [1 ]
机构：
[1] Amer Univ, Dept Internal Med, Beirut Med Ctr, Beirut, Lebanon
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 11卷
关键词：
AML; allotransplant; relapse; immunotherapy; Graft versus leukaemia (GVL); ACUTE MYELOID-LEUKEMIA; DONOR LYMPHOCYTE INFUSIONS; RETROSPECTIVE MULTICENTER ANALYSIS; MYELODYSPLASTIC SYNDROME; MYELOGENOUS LEUKEMIA; FLOW-CYTOMETRY; OLDER PATIENTS; RISK-FACTORS; AZACITIDINE; CHEMOTHERAPY;
D O I：
10.3389/fonc.2021.793274
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Relapsed acute myeloid leukemia (AML) following allogeneic hematopoietic cell transplantation (allo-HCT) is an unfavorable event associated with a poor prognosis, particularly for patients with early relapses. It usually arises from resistant leukemic blasts that escaped both preparative chemotherapy regimen and the graft-versus-leukemia (GVL) effect. Independent from the choice of salvage treatment, only minority of patients can achieve durable remissions. In recent years, better understanding of the disease relapse biology post allo-HCT allowed the application of newer strategies that could induce higher rates of remission, and potential longer survival. Those strategies aim at optimizing drugs that have a direct anti-leukemia activity by targeting different oncogenic mutations, metabolism pathways or surface antigens, and concurrently enhancing the immune microenvironment to promote GVL effect. This review discusses the current treatment landscape of AML relapse post allo-HCT.
引用
收藏
页数：8
相关论文
共 78 条
[1]   Successful venetoclax and Actinomycin D-based treatment for relapsed acute myeloid leukemia post allogeneic hematopoietic cell transplantation [J].
Abou Dalle, Iman ;
Bazarbachi, Ali .
BONE MARROW TRANSPLANTATION, 2021, 56 (11) :2626-2627
[2]   The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia [J].
Abou Dalle, Iman ;
DiNardo, Courtney D. .
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (07) :163-173
[3]   Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia [J].
Aldoss, Ibrahim ;
Yang, Dongyun ;
Aribi, Ahmed ;
Ali, Haris ;
Sandhu, Karamjeet ;
Al Malki, Monzr M. ;
Mei, Matthew ;
Salhotra, Amandeep ;
Khaled, Samer ;
Nakamura, Ryotaro ;
Snyder, David ;
O'Donnell, Margaret ;
Stein, Anthony S. ;
Forman, Stephen J. ;
Marcucci, Guido ;
Pullarkat, Vinod .
HAEMATOLOGICA, 2018, 103 (09) :E404-E407
[4]   Pharmacologic Therapies to Prevent Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation [J].
Antar, Ahmad, I ;
Otrock, Zaher K. ;
Abou Dalle, Iman ;
El-Cheikh, Jean ;
Bazarbachi, Ali .
FRONTIERS IN ONCOLOGY, 2020, 10
[5]   Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation [J].
Bastos-Oreiro, Mariana ;
Perez-Corral, Ana ;
Martinez-Laperche, Carolina ;
Bento, Leyre ;
Pascual, Cristina ;
Kwon, Mi ;
Balsalobre, Pascual ;
Munoz, Cristina ;
Buces, Elena ;
Serrano, David ;
Gayoso, Jorge ;
Buno, Ismael ;
Anguita, Javier ;
Luis Diez-Martin, Jose .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (03) :239-246
[6]   Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-Like Tyrosine Kinase 3-Mutated Acute Myeloid Leukemia [J].
Battipaglia, Giorgia ;
Ruggeri, Annalisa ;
Massoud, Radwan ;
El Cheikh, Jean ;
Jestin, Matthieu ;
Antar, Ahmad ;
Ahmed, Syed Osman ;
Rasheed, Walid ;
Shaheen, Marwan ;
Belhocine, Ramdane ;
Brissot, Eolia ;
Dulery, Remy ;
Eder, Sandra ;
Giannotti, Federica ;
Isnard, Francoise ;
Lapusan, Simona ;
Rubio, Marie-Therese ;
Vekhoff, Anne ;
Aljurf, Mahmoud ;
Legrand, Ollivier ;
Mohty, Mohamad ;
Bazarbachi, Ali .
CANCER, 2017, 123 (15) :2867-2874
[7]   Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years [J].
Bazarbachi, Ali ;
Schmid, Christoph ;
Labopin, Myriam ;
Beelen, Dietrich ;
Blau, Igor Wolfgang ;
Potter, Victoria ;
Niittyvuopio, Riitta ;
Socie, Gerard ;
Blaise, Didier ;
Sanz, Jaime ;
Ciceri, Fabio ;
Abou Dalle, Iman ;
Spyridonidis, Alexandros ;
Bug, Gesine ;
Esteve, Jordi ;
Savani, Bipin N. ;
Nagler, Arnon ;
Mohty, Mohamad .
CLINICAL CANCER RESEARCH, 2020, 26 (24) :6475-6482
[8]   Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation [J].
Bazarbachi, Ali ;
Bug, Gesine ;
Baron, Frederic ;
Brissot, Eolia ;
Ciceri, Fabio ;
Abou Dalle, Iman ;
Dohner, Hartmut ;
Esteve, Jordi ;
Floisand, Yngvar ;
Giebel, Sebastian ;
Gilleece, Maria ;
Gorin, Norbert-Claude ;
Jabbour, Elias ;
Aljurf, Mahmoud ;
Kantarjian, Hagop ;
Kharfan-Dabaja, Mohamed ;
Labopin, Myriam ;
Lanza, Francesco ;
Malard, Florent ;
Peric, Zinaida ;
Prebet, Thomas ;
Ravandi, Farhad ;
Ruggeri, Annalisa ;
Sanz, Jaime ;
Schmid, Christoph ;
Shouval, Roni ;
Spyridonidis, Alexandros ;
Versluis, Jurjen ;
Vey, Norbert ;
Savani, Bipin N. ;
Nagler, Arnon ;
Mohty, Mohamad .
HAEMATOLOGICA, 2020, 105 (06) :1507-1516
[9]   Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study [J].
Ali Bazarbachi ;
Myriam Labopin ;
Giorgia Battipaglia ;
Azedine Djabali ;
Edouard Forcade ;
William Arcese ;
Gerard Socié ;
Didier Blaise ;
Joerg Halter ;
Sabine Gerull ;
Jan J. Cornelissen ;
Patrice Chevallier ;
Johan Maertens ;
Nicolaas Schaap ;
Jean El-Cheikh ;
Jordi Esteve ;
Arnon Nagler ;
Mohamad Mohty .
Clinical Hematology International, 2019, 1 (1) :58-74
[10]   Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party [J].
Bazarbachi, Ali ;
Labopin, Myriam ;
Battipaglia, Giorgia ;
Djabali, Azedine ;
Passweg, Jakob ;
Socie, Gerard ;
Forcade, Edouard ;
Blaise, Didier ;
Chevallier, Patrice ;
Orvain, Corentin ;
Cornelissen, Jan J. ;
Arcese, William ;
Chantepie, Sylvain ;
Hashaishi, Khowla ;
El Cheikh, Jean ;
Medinger, Michael ;
Esteve, Jordi ;
Nagler, Arnon ;
Mohty, Mohamad .
HAEMATOLOGICA, 2019, 104 (09)
12345678